Zubsolv (buprenorphine/naloxone) — Point32Health
Opioid dependence
Preferred products
- buprenorphine/naloxone tablets
- buprenorphine/naloxone films
Initial criteria
- Documented diagnosis of opioid dependence
- Documentation of an adverse reaction to buprenorphine/naloxone tablets or films that is allergic in nature, or cannot be expected or managed during the course of buprenorphine therapy
Approval duration
12 months